Cocktail party: Low-dose antibody combinations deliver pan-ebolavirus protection.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 35303426.
- Also identified by DOI 10.1016/j.cell.2022.01.025.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent outbreaks of Ebola have brought to the forefront the need for focused therapeutic treatments. In this issue of Cell, Milligan and colleagues build on previous studies of antibody treatments for Ebola virus disease, uncovering broad synergistic protective immunity when administered in combination (as antibody cocktails).
Medical subject headings
- Ebolavirus
- Hemorrhagic Fever, Ebola